Drugs / OPF-110
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07848334 | Aug → Oct 2026 expected | — | Otsuka Pharmaceutical Factory, Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPF-110 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07848334 ↗ |
| Modality | Other / unclassified | “lipid injectable emulsion” NCT07848334 ↗ |
| Route | Intravenous | “administered by intravenous infusion” NCT07848334 ↗ |